Literature DB >> 23064148

Runx1: no longer just for leukemia.

Ichiro Taniuchi1, Motomi Osato, Yoshiaki Ito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23064148      PMCID： PMC3492739          DOI： 10.1038/emboj.2012.282

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  11 in total

1.  Sequence analysis of mutations and translocations across breast cancer subtypes.

Authors:  Shantanu Banerji; Kristian Cibulskis; Claudia Rangel-Escareno; Kristin K Brown; Scott L Carter; Abbie M Frederick; Michael S Lawrence; Andrey Y Sivachenko; Carrie Sougnez; Lihua Zou; Maria L Cortes; Juan C Fernandez-Lopez; Shouyong Peng; Kristin G Ardlie; Daniel Auclair; Veronica Bautista-Piña; Fujiko Duke; Joshua Francis; Joonil Jung; Antonio Maffuz-Aziz; Robert C Onofrio; Melissa Parkin; Nam H Pho; Valeria Quintanar-Jurado; Alex H Ramos; Rosa Rebollar-Vega; Sergio Rodriguez-Cuevas; Sandra L Romero-Cordoba; Steven E Schumacher; Nicolas Stransky; Kristin M Thompson; Laura Uribe-Figueroa; Jose Baselga; Rameen Beroukhim; Kornelia Polyak; Dennis C Sgroi; Andrea L Richardson; Gerardo Jimenez-Sanchez; Eric S Lander; Stacey B Gabriel; Levi A Garraway; Todd R Golub; Jorge Melendez-Zajgla; Alex Toker; Gad Getz; Alfredo Hidalgo-Miranda; Matthew Meyerson
Journal:  Nature       Date:  2012-06-20       Impact factor: 49.962

Review 2.  RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.

Authors:  L S H Chuang; Y Ito
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

3.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

Authors:  H Miyoshi; K Shimizu; T Kozu; N Maseki; Y Kaneko; M Ohki
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 4.  Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins.

Authors:  Jurian Schuijers; Hans Clevers
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

Review 5.  The RUNX genes: gain or loss of function in cancer.

Authors:  Karen Blyth; Ewan R Cameron; James C Neil
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

6.  Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors.

Authors:  Ming Yu; Tali Mazor; Hui Huang; Hsuan-Ting Huang; Katie L Kathrein; Andrew J Woo; Candace R Chouinard; Adam Labadorf; Thomas E Akie; Tyler B Moran; Huafeng Xie; Sima Zacharek; Ichiro Taniuchi; Robert G Roeder; Carla F Kim; Leonard I Zon; Ernest Fraenkel; Alan B Cantor
Journal:  Mol Cell       Date:  2012-02-10       Impact factor: 17.970

7.  Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.

Authors:  Cornelia Johanna Franziska Scheitz; Tae Seung Lee; David James McDermitt; Tudorita Tumbar
Journal:  EMBO J       Date:  2012-10-02       Impact factor: 11.598

8.  Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.

Authors:  Gareth Brady; Hannah J Whiteman; Lindsay C Spender; Paul J Farrell
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

9.  AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.

Authors:  T Okuda; J van Deursen; S W Hiebert; G Grosveld; J R Downing
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

10.  Whole-genome analysis informs breast cancer response to aromatase inhibition.

Authors:  Matthew J Ellis; Li Ding; Dong Shen; Jingqin Luo; Vera J Suman; John W Wallis; Brian A Van Tine; Jeremy Hoog; Reece J Goiffon; Theodore C Goldstein; Sam Ng; Li Lin; Robert Crowder; Jacqueline Snider; Karla Ballman; Jason Weber; Ken Chen; Daniel C Koboldt; Cyriac Kandoth; William S Schierding; Joshua F McMichael; Christopher A Miller; Charles Lu; Christopher C Harris; Michael D McLellan; Michael C Wendl; Katherine DeSchryver; D Craig Allred; Laura Esserman; Gary Unzeitig; Julie Margenthaler; G V Babiera; P Kelly Marcom; J M Guenther; Marilyn Leitch; Kelly Hunt; John Olson; Yu Tao; Christopher A Maher; Lucinda L Fulton; Robert S Fulton; Michelle Harrison; Ben Oberkfell; Feiyu Du; Ryan Demeter; Tammi L Vickery; Adnan Elhammali; Helen Piwnica-Worms; Sandra McDonald; Mark Watson; David J Dooling; David Ota; Li-Wei Chang; Ron Bose; Timothy J Ley; David Piwnica-Worms; Joshua M Stuart; Richard K Wilson; Elaine R Mardis
Journal:  Nature       Date:  2012-06-10       Impact factor: 49.962
View more
  17 in total

1.  Crlz-1 is prominently expressed in spermatogonia and Sertoli cells during early testis development and in spermatids during late spermatogenesis.

Authors:  Jung-Hyun Lim; Seong-Young Choi; Han-Woong Yoo; Sun-Jung Cho; Youngsook Son; Chang-Joong Kang
Journal:  J Histochem Cytochem       Date:  2013-03-22       Impact factor: 2.479

2.  Applicability of gene expression profile of childhood acute lymphoblastic leukemia at diagnosis and at the end of the induction phase of chemotherapy at a cancer hospital in the state of Goiás (Brazil).

Authors:  Lysa B Minasi; Fernanda R Godoy; Daniela de M e Silva; Thaís C Vieira; Cláudio C da Silva; Aparecido D da Cruz
Journal:  Tumour Biol       Date:  2013-09-20

3.  Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion.

Authors:  Gillian Browne; Hanna Taipaleenmäki; Nicole M Bishop; Sharath C Madasu; Leslie M Shaw; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

4.  The primary pulmonary NUT carcinomas and some uncommon somatic mutations identified by next-generation sequencing: a case report.

Authors:  Ying Liu; Yan-Ying Li; Xue-Xuan Ke; You Lu
Journal:  AME Case Rep       Date:  2020-10-30

5.  RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.

Authors:  Maaike P A van Bragt; Xin Hu; Ying Xie; Zhe Li
Journal:  Elife       Date:  2014-11-21       Impact factor: 8.140

6.  RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.

Authors:  Nyam-Osor Chimge; Gillian H Little; Sanjeev K Baniwal; Helty Adisetiyo; Ying Xie; Tian Zhang; Andie O'Laughlin; Zhi Y Liu; Peaches Ulrich; Anthony Martin; Paulette Mhawech-Fauceglia; Matthew J Ellis; Debu Tripathy; Susan Groshen; Chengyu Liang; Zhe Li; Dustin E Schones; Baruch Frenkel
Journal:  Nat Commun       Date:  2016-02-26       Impact factor: 14.919

7.  RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells.

Authors:  A Rasim Barutcu; Deli Hong; Bryan R Lajoie; Rachel Patton McCord; Andre J van Wijnen; Jane B Lian; Janet L Stein; Job Dekker; Anthony N Imbalzano; Gary S Stein
Journal:  Biochim Biophys Acta       Date:  2016-08-09

Review 8.  RUNX1: A microRNA hub in normal and malignant hematopoiesis.

Authors:  Stefano Rossetti; Nicoletta Sacchi
Journal:  Int J Mol Sci       Date:  2013-01-14       Impact factor: 5.923

9.  Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer.

Authors:  Nicola Ferrari; Zahra M A Mohammed; Colin Nixon; Susan M Mason; Elizabeth Mallon; Donald C McMillan; Joanna S Morris; Ewan R Cameron; Joanne Edwards; Karen Blyth
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

10.  RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes.

Authors:  María Sol Recouvreux; Esteban Nicolás Grasso; Pablo Christian Echeverria; Luciana Rocha-Viegas; Lucio Hernán Castilla; Carolina Schere-Levy; Johanna Melisa Tocci; Edith Claudia Kordon; Natalia Rubinstein
Journal:  Oncotarget       Date:  2016-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.